Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates Nov 13, 2025 08:30AM
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025 Oct 24, 2025 08:00AM
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024 Oct 23, 2024 08:45AM
Lantern Pharma to Present at the ThinkEquity Conference on October 19 at 1:30 p.m. ET Oct 10, 2023 08:00AM
Lantern Pharma to Present at the ThinkEquity Conference on Wednesday, October 26 at 1:00 p.m. ET Oct 21, 2022 07:00AM


Oct 5, 2022 08:00AM Lantern Pharma to Present at Upcoming Investor Conferences
Aug 8, 2022 04:01PM Lantern Pharma Reports Second Quarter 2022 Financial Results and Operational Highlights
Jan 20, 2021 04:00PM Lantern Pharma Announces Closing of Public Offering of $69 Million USD and Full Exercise of Underwriter's Over-Allotment Option
Jan 15, 2021 05:56AM Lantern Pharma (LTRN) Prices 4.28M Share IPO at $14/Sh
Jan 14, 2021 09:30PM Lantern Pharma Announces Pricing of $60 Million Public Offering
Jun 15, 2020 03:53PM Lantern Pharma Announces Closing of Initial Public Offering